Memory loss Muscle weakness Loss of voluntary movement Dementia Hallucinations Seizures Jerky body movements Tremors Rigidity Confusion Depression Language.

Slides:



Advertisements
Similar presentations
Sporadic AD familial AD etiology environmental factors, genetic predisposition etiology oligomerization of A 42 and initial (diffuse) A 42 deposits subtle.
Advertisements

Jessica Price Advanced Cell and Molecular Biology Lake Forest College
Parkinson’s disease: February 19th BIOS E108 Parkin and PINK1
Cell Structure. Cytoplasm  All of the cellular contents between the plasma membrane and the nucleus.
Early-onset forms of Parkinson’s disease Dr. Pupak Derakhshandeh (PhD) Assis. Prof. Med. Sci. of Tehran Univ Dr. Pupak Derakhshandeh (PhD) Assis. Prof.
Knowledge and Attitudes Toward Genetic Testing in Parkinson’s Disease Dana Lundberg 2006.
Genetic Screening for Alzheimer’s Disease Thorstensen: Genetic Screening for Alzheimer's Disease 1.
Sara Herrera Advisor: Shubhik K. DebBurman Department of Biology Lake Forest College New  -Synuclein Mutants: How Do They Contribute To Parkinson’s Disease?
Intracellular Compartments ER, Golgi, Endsomes, Lysosomes and Peroxisomes.
Α-Synuclein Interaction with Phospholipids: Possible Implications for Parkinson’s Disease Literature Seminar by Jessica L. Anderson.
September 13th BIOS E108 Parkinson’s disease (PD) -Pathology -Diagnosis -  -synuclein.
PHL 437/Pharmacogenomics Fourth Lecture (Parkinson’s disease) By Abdelkader Ashour, Ph.D. Phone:
Parkinson’s Disease Pathology 430/826 The Molecular Basis of Disease Neurological Genetics 9 th March 2015 Dr. John Rossiter
DEMENTIA By: Angela Pabon. What is Dementia? Dementia does not always mean that one has Alzheimer's disease, there are over 80 forms of dementia The definition.
Lewy Bodies in PD. Lewy Body Inclusions and the effect of coffee and decaffeinated extracts on Drosophila neuronal cultures.
NERVOUS SYSTEM DISEASES NOTES. CEREBRAL PALSY: WHAT IS IT? Muscle spasms/tightness Involuntary movements Problems with balance Awkward gait Can be minor.
Module 7.3 Movement Disorders. Parkinson’s Disease A neurological disorder characterized by muscle tremors, rigidity, slow movements and difficulty initiating.
What is Aging? Alzheimer’s Disease Parkinson’s Disease.
Gene Therapy in Huntington’s Disease Project was done by Rejan Chin & Sharisa Ford.
HEXA and Tay-Sachs Disease
Chapter 21. Molecular Mechanisms of Neurological Disease Copyright © 2014 Elsevier Inc. All rights reserved.
The Importance of Non-conserved Regions in Protein Remodeling by the E. coli Molecular Chaperone, ClpB Zakiya Qualls.
Early-onset forms of Parkinson’s disease Dr. Pupak Derakhshandeh (PhD) Assis. Prof. Med. Sci. of Tehran Univ Dr. Pupak Derakhshandeh (PhD) Assis. Prof.
Α-synuclein, Lewy Bodies, Prions, and Parkinson’s Disease Cody McCullough & Sara Homsi BCM 465 April 19 th, 2010.
Parkinson’s Disease superKAT :).
1 Introduction(1/2)  Eukaryotic cells can synthesize up to 10,000 different kinds of proteins  The correct transport of a protein to its final destination.
 Phospholipid bilayer  “Mosaic” of proteins The fluid-mosaic model.
Alzheimer’s Disease By: Chelcy Branon. Facts  In 2006, there were 26.6 million sufferers worldwide  Costs 100 billion dollars per year.
10 signs to early detection 1. Memory loss that affects daily life 2. Challenges in planning or solving problems 3. Difficulty completing projects at.
New Cellular Models for Drug Discovery in Alzheimer’s Disease Jordan L. Holtzman, M.D.,Ph.D. 1,2,3 (1) Division of Environmental Health Sciences (2) Departments.
Michael Cummings David Reisman University of South Carolina Gene Regulation Part 2 Chapter 9.
Advances in polyglutamine disease research & therapy
Alkaline pH sensing in Candida albicans
A mitochondrial quality control pathway revealed from studies of familial Parkinson’s Disease genes Leo Pallanck Department of Genome Sciences.
Identification of Novel Factors Involved in Vesicle Formation at the Multivesicular Body in Yeast Erika Hanson Stevens Lab.
Javad Jamshidi Fasa University of Medical Sciences, October 2015 Eukaryotic Cell Organelles and Organization.
Mounting Evidence that Endocytosis Regulates  -Synuclein Degradation Jaime Pérez Pineda Advanced Cell Biology Fall 2009.
Bioinformatics: Practical Application of Simulation and Data Mining Protein Aggregation I Prof. Corey O’Hern Department of Mechanical Engineering & Materials.
By Katelyn Chaimson and Sean Guyot
Α-synuclein transgenic mouse models of Parkinson’s disease Michelle Maurer December 2015.
Yeast Lab 2 To do today: 1.Make lysates of WT, sec18 & sec61 strains grown at RT & 37°C. 2.Run lysates on 12% SDS- PAGE gel. 3.Score results from yeast.
AP Biology Eukaryotic Genome Control Mechanisms for Gene expression.
Parkinson’s Disease Sheila Mulhern. Parkinson’s Disease Stats (PDF)  One million Americans live with Parkinson's disease, - more than the combined number.
 Parkinson Disease (PD) is a progressive disorder of the central nervous system that often impairs the sufferer's motor skills, speech, and other functions.
Pathogenesis and pathology of parkinsonism
Cytoplasmic membranes-1 Unit objective: To understand that materials in cell are shuttled from one part to another via an extensive membrane network.
Do Now 2/9/15 1.Describe possible causes for forgetting a memory. 2.Compare and contrast semantic and episodic memories.
Alzheimer’s Disease and the influence of Presenilin 1
Parkinson’s Disease.
CLINICAL CORRELATIONS
Module 7.3 Movement Disorders
BISC 220 Lab—Series 2 Protein Transport through the Secretory Pathway
Protein conformational disorders
Protein Folding Diseases
CLINICAL CORRELATIONS
Advisor: Shubhik K. DebBurman Department of Biology
III. Parkinson Disease.
Long Term Effects of Concussions
Alpha-synuclein in Parkinson's disease
What does this protein make up or do?
Understanding the structure of a protein involved in Parkinson’s disease -My research proposal was “Relating the structure of aggregated alpha synuclein.
Parkinson’s Diseased Proteins in Relation to Autophagy
Understanding the structure of a protein involved in Parkinson’s disease -My research proposal was “Relating the structure of aggregated alpha synuclein.
The Role of Astrocyte Dysfunction in Parkinson’s Disease Pathogenesis
CLINICAL CORRELATIONS
STP2 & GAPDH: Partners in crime towards -Synuclein Toxicity
Parkinson's Disease Neuron
Neuronal Aggregates: Formation, Clearance, and Spreading
Volume 20, Issue 1, Pages (January 2011)
PD-associated gene products and their prospective sites of cellular function PD is hypothesized to be a consequence of the dysfunction of intersecting.
Presentation transcript:

Memory loss Muscle weakness Loss of voluntary movement Dementia Hallucinations Seizures Jerky body movements Tremors Rigidity Confusion Depression Language problems Stiff muscles Ataxia Personality changes Decline in mental abilities

Assessing  -Synuclein Degradation through the MVB/Endocytosis Pathway Jaime Pérez BIOL 324 Grant Proposal Defense

Common Problem Parkinson’s Disease Alzheimer’s Disease Huntington’s Disease Prion Disease ALS  -Synuclein Amyloid-  peptide Huntingtin Prion protein SOD1 Misfolding & Aggregation Cell Death DiseaseCulprit Protein

Common Problem Parkinson’s Disease Alzheimer’s Disease Huntington’s Disease Prion Disease ALS  -Synuclein Amyloid-  peptide Huntingtin Prion protein SOD1 Misfolding & Aggregation Cell Death DiseaseCulprit Protein

Road Map Background: PD &  -Synuclein Major Questions Why Endocytosis? Hypothesis Yeast Model Specific Aims Methods Preliminary Results Why is this important?

Parkinson’s Disease Facts 4 million people affected Classic symptoms: Resting tremors Muscular rigidity No known cure Muhammad Ali & Michael J. Fox

Parkinson’s Disease Substantia Nigra Basal Ganglia Motor Cortex Muscle  Less Movement Giasson, B.I., et al. (1999). Spillantini, M.G., et al. (1998). Abeliovich, A., et al. (2000).

My Interest in  - Synuclein Lewy Bodies:  - Synuclein inclusions Spillantini, M., et al. (1998).

What is  -Synuclein? 140 amino acid protein Associated with 1. Synaptic membranes 2. Secretory pathway Jakes, R., et al. (1994). Davidson, W. S., et al. (1998). Dixon, C., et al. (2005). NNACC

 - Synuclein and PD SPORADICFAMILIAL Normal  -synuclein Misfolded Accumulated Genes:  -synuclein parkin UCH-L1 DJ-1 PINK1 LRRK2 DNA Point mutations Polymeropoulos, M.H., et al. (1997), Kitada, T., et al. (1998) Funayama, M., et al. (2002), Bonifati V., et al. (2003). Valente, E. M., et al. (2004), Paisan-Ruiz, C., et al. (2004). Toxins Environmental factors A30P, A53T, E46K Wild Type  -synuclein CELL DEATH

Gain of Function Disease PD-like symptoms WT & familial mutants (A30P & A53T) Feany, M., et al. (2000). Lasko, M., et al. (2003). Masilah, E., et al. (2000).

Major Questions in Field Is  -synuclein even toxic? If so, what is causative agent? Are Lewy bodies involved in onset?  -synuclein accumulation causing PD? Essential to examine  -synuclein degradation routes Alpha-synuclein THERAPY!

Proteins 1.VERY Important 2. Shape and Function Normal  -synuclein Misfolded Accumulated

Degradation Pathways Proteasome Lysosome Degrades proteins from cytoplasm or nucleus Degrades proteins from plasma membrane or outside cell  -synuclein literature: Rideout, H. J., et al. (2002). Sawada, H., et al. (2003). Bedford, L., et al. (2008). … Evidence UCHL1 parkin

Lysosome Outside Cell Inside Cell

Lysosome Autophagy Literature Lee, H.J., et al. (2004). Ancolio, K., et al. (2000). Cuervo, A. M., et al. (2004). Vogliatzi, T., et al. (2008). Webb, J. L., et al. (2003).

Cell Cytoplasm Late Endosome Lysosome Early Endosome MVB Outside Endocytosis lit.: Willingham, S., et al. (2003). Kuwahara, T., et al. (2008). Lee, H.J., et al. (2008). … Why Endocytosis?

ESCRT Machinery Endosomal Sorting Complexes Required for Transport Katzmann, D. J., et al. (2002). Katzmann, D. J., et al. (2001). Katzmann, D. J., et al. (2003). Ayala, A. (2009).

Functions vps27: Protein that forms a complex with Hse1p; required for recycling Golgi proteins, forming lumenal membranes and sorting ubiquitinated proteins destined for degradation vps34: Kinase responsible for the synthesis of one phospholipid; forms membrane complex with Vps15p to regulate protein sorting Yeast Genome Database vps34 vps27 MVB Cargo Endosome Lumen Off to ESCRT-1 Endosome Membrane

Gap in Knowledge The MVB/endosome pathway is a route through which  -synuclein is targeted to the lysosome Is alpha-synuclein being degraded through the MVB/endosome pathway? Hypothesis

Why Budding Yeast? Easy to grow Cost effective Genome sequence available ESCRT genes conserved in humans MVB/endosome pathway best studied in yeast Outeiro, T.F., et al. (2003). Willingham, S., et al. (2003).

Specific Aims Assess  -synuclein… 1. Accumulation 2. Localization 3. Toxicity in cells compromised for endocytosis at the pre-ESCRT step

PYES.2 Plasmid GAL  -Syn GFP V5 URA-3

Transformation Yeast LiAc Heat Shock ssDNA Vector YPD -URA GLU

Yeast Constructs PP GFP WT A30P E46K URA-3 GAL GFP V5 URA-3 GAL GFP V5 URA-3  -Syn GAL GFP V5 URA-3  -Syn GAL GFP V5 URA-3  -Syn vps27  vps34  BY4741 Controls

Rationales Accumulation –Western Blot Ayala, A. (2009) & Sharma, N., et al (2006). –Loss of Induction Localization –GFP Microscopy Outeiro, T.F., et al. (2003), Nobel Prize 2008 Toxicity –Growth Curves Ayala, A. (2009) & Sharma, N., et al (2006). –Spotting

Aim One Assess a-synuclein accumulation in cells compromised for endocytosis at pre-ESCRT step.

Accumulation: Western Blot Method: V5 PGK 24 hr GAL Heat SDS Class Beads Protein Gel Membrane Y Y Anti-PGK Anti-V5

Accumulation: Loss of Induction Method: V5 PGK 24 hr GAL Heat SDS Class Beads Protein GelMembrane Y Y Anti-PGK Anti-V5 24 hr GLU 0 hr GLU 6 hr GLU 12 hr GLU

Predictions Anti-PGK Anti-V5 BY4741 vps  Gal MW Glu Loss of Induction BY4741 vps  WT A30P E46K GFP MW

Aim Two Assess a-synuclein localization in cells compromised for endocytosis at pre-ESCRT step.

Localization: GFP Microscopy Method:

Predictions 24 hr GFP WT 48 hr 24 hr WT E46K 48 hr BY4741 vps  A30PE46K

Aim Three Assess a-synuclein toxicity in cells compromised for endocytosis at pre-ESCRT step.

Toxicity: Growth Curves Method: Spectrophotometer Culture GAL Time Absorbance

Toxicity: Spotting GLU GAL

Predictions Time Absorbance 4741, PP, GFP  -Syn GLU 4741, PP, GFP  -Syn GAL 4741, PP, GFP  -Syn

Repeats and Analysis StrainODSPWBLOIMC vps27  _ _ __ vps34  ___  AnalysisCumulative & with t-test N/A Graph

Preliminary Data: vps34 PP GFP WT A30P E46K Galactose Glucose PP GFP WT A30P E46K Galactose Glucose PP GFP WT A30P E46K Galactose Glucose PP GFP WT A30P E46K Galactose Glucose PP GFP WT A30P E46K Galactose Glucose PP GFP WT A30P E46K Galactose Glucose PP GFP WT A30P E46K Galactose Glucose BY4741 vps37  WT A30P E46K GFP anti-PGK anti-V5 MW BY4741 vps37  WT A30P E46K GFP anti-PGK anti-V5 MW BY4741 vps37  WT A30P E46K GFP anti-PGK anti-V5 MW BY4741 vps34  WT A30P E46K GFP MW Anti-V5 Anti-PGK 24 hr 48 hr GFP WT A30P E46K

Lysates 34 MC 27 Western 34 Lysates 27Western 27 OD 27 SP 27 Western 27 REPEATS and LOI if necessary

Why Important to Study? Hardships, inconvenience, and cost: –NEED to understand mechanism that will lead to cure! We are training well-prepared undergraduates for diverse biological careers in research, medicine and allied health.